Daily Anesthesiology Research Analysis
Analyzed 24 papers and selected 3 impactful papers.
Summary
Three perioperative/translational studies stand out today: a translational biomarker/target study identifying CSF aquaporin-4 as a predictor and therapeutic target for paraplegia after endovascular TAAA repair; a multicenter validation demonstrating the utility and limits of Japan’s DPC administrative data for ICU research; and a nationwide Italian experience showing prolonged TA-NRP in cDCD heart-lung procurement does not compromise lung transplant outcomes.
Research Themes
- Perioperative neuroprotection and spinal cord ischemia
- Critical care data validity and real-world evidence
- Transplant donor management and regional perfusion strategies
Selected Articles
1. Aquaporin-4: A Predictor and Therapeutic Target for Permanent Paraplegia after Endovascular Thoracoabdominal Aortic Aneurysm Repair.
CSF aquaporin-4 (AQP4) levels were approximately fourfold higher in patients who remained permanently paraplegic after endovascular TAAA repair, correlated with greater spinal cord edema on T2-weighted MRI. In a rodent ischemic spinal cord injury model, pharmacologic AQP4 inhibition preserved neurons/glia and reduced paraplegia, positioning AQP4 as both a prognostic biomarker and a therapeutic target.
Impact: Provides a human biomarker (CSF AQP4) with mechanistic validation and therapeutic tractability for a catastrophic perioperative complication. Bridges clinical proteomics with interventional animal data.
Clinical Implications: CSF AQP4 could support early risk stratification and monitoring after TAAA repair; AQP4 modulation may be explored as a neuroprotective strategy to prevent ischemia-induced paraplegia.
Key Findings
- CSF AQP4 was ~4-fold higher in patients with permanent paraplegia (41.8 ± 19.2 ng/mL) versus transient paraplegia or none (~10.8 ng/mL); p=0.01 and p=0.004 respectively.
- CSF AQP4 >15 ng/mL was associated with greater T2-weighted MRI cord edema (1.77 ± 0.19 vs 1.03 ± 0.36; p=0.03).
- In rodents, AQP4 inhibition preserved neurons/glia in dorsal horn/white matter (p=0.004) and protected against ischemia-induced paraplegia (p<0.001).
- Translational approach integrated human CSF proteomics with in vivo target interrogation.
Methodological Strengths
- Proteomic biomarker discovery in human CSF with clinically adjudicated neurologic outcomes and MRI correlates.
- Causal target interrogation via pharmacologic AQP4 inhibition in a relevant ischemic spinal cord model.
Limitations
- Small human sample size (n=37) and observational design limit generalizability.
- No randomized clinical intervention; external validation cohorts and standardized AQP4 assays are needed.
Future Directions: Prospective validation of CSF AQP4 thresholds, development of rapid assays, and early-phase trials testing AQP4 modulators for perioperative neuroprotection.
OBJECTIVE: Endovascular thoracoabdominal aortic aneurysm (TAAA) repair can impair spinal cord perfusion, leading to paraplegia. The mechanisms driving this devastating complication are poorly understood. This study aimed to interrogate the cerebrospinal fluid (CSF) proteome in patients after TAAA repair to identify biomarkers that herald permanent paraplegia. It also aimed to investigate a potential therapeutic target identified by proteomics using an in vivo model of ischaemic spinal cord injur
2. LUNG TRANSPLANTATION AFTER PROLONGED TA-NRP IN COMBINED HEART-LUNG PROCUREMENT FROM CONTROLLED DCD DONORS IN ITALY.
In a nationwide Italian cohort of cDCD heart-lung procurements, 16 lungs were bilaterally transplanted after prolonged TA-NRP (median 125 minutes). Short- to medium-term outcomes were acceptable: ICU stay averaged 6 days, PGD grade 3 at 72 hours was 12.5%, in-hospital mortality 6.2%, and two additional post-discharge deaths due to infection. Prolonged TA-NRP did not compromise lung transplant outcomes.
Impact: Directly informs procurement strategies where prolonged TA-NRP is unavoidable, demonstrating lung viability and acceptable outcomes in combined heart-lung retrieval from cDCD donors.
Clinical Implications: Supports the use of prolonged TA-NRP for heart assessment without sacrificing lung transplantability in cDCD settings; may expand donor utilization and guide perfusion/venting strategies.
Key Findings
- Among 24 cDCD donors evaluated for combined heart-lung procurement, 16 lungs were retrieved and bilaterally transplanted (median recipient age 54 years).
- Median TA-NRP duration was 125 minutes; functional warm ischemia and asystolic times were 36 and 25 minutes, respectively.
- ICU stay averaged 6 days; PGD grade 3 at 72 hours occurred in 12.5% of recipients.
- In-hospital mortality was 6.2%; two additional post-discharge deaths (12.5%) were due to infections.
- Four recipients required EVLP; outcomes remained acceptable, indicating feasibility despite prolonged TA-NRP.
Methodological Strengths
- Nationwide, real-world cohort reflecting unique regulatory constraints (20-minute stand-off).
- Detailed reporting of ischemic times, TA-NRP duration, EVLP use, and clinically meaningful outcomes (PGD, ICU stay, mortality).
Limitations
- Small sample size and absence of a contemporaneous non-TA-NRP control group.
- Observational design limits causal inference; long-term outcomes beyond early post-transplant are limited.
Future Directions: Prospective multicenter comparisons of TA-NRP durations, standardized perfusion/venting protocols, and long-term graft outcomes; development of lung-specific biomarkers during TA-NRP.
Thoraco-abdominal normothermic regional perfusion(TA-NRP) is an emerging strategy for heart recovery in controlled donation after circulatory death(cDCD). Its impact on lung graft retrieval remains debated, especially regarding the duration of TA-NRP. This is particularly relevant in Italy, where the world's longest mandatory stand-off period(20 minutes) leads to prolonged TA-NRP for heart assessment. This study evaluates the impact of TA-NRP on lung transplant(LT) outcomes in a nationwide exp
3. Validation of the Diagnosis Procedure Combination Database in Japan for ICU Research: A Multicenter Comparison with the Japanese Intensive care PAtient Database (JIPAD).
In 14,070 matched ICU admissions across four centers, the DPC administrative database showed high sensitivity/specificity (≥80%) for most ICU variables and near-perfect mortality coding (in-hospital 99.1%/100.0%; ICU 96.2%/99.9%). Sensitivity was low for several comorbidities and for noninvasive respiratory supports (NIPPV 5.5%; HFNC 36.1%), and SOFA scores had moderate agreement (ICC 0.61).
Impact: Establishes where DPC data are robust versus where caution is required, enabling more reliable ICU epidemiology and health services research in Japan.
Clinical Implications: Supports use of DPC for ICU outcomes and interventions but recommends complementary clinical data for comorbidities, noninvasive ventilation, and organ dysfunction scoring.
Key Findings
- Included 14,070 ICU admissions matched between DPC and JIPAD across four Japanese ICUs.
- High sensitivity/specificity (≥80%) for most demographics, major diagnostic categories, ICU interventions, and mortality.
- Sensitivity was low for several comorbidities; specificity remained >95%.
- Noninvasive respiratory support was undercaptured (NIPPV sensitivity 5.5%; HFNC 36.1%) with high specificity (97.3%–99.9%).
- SOFA scores showed moderate agreement (ICC 0.61); mortality coding was near-perfect (in-hospital 99.1%/100.0%, ICU 96.2%/99.9%).
Methodological Strengths
- Multicenter retrospective validation against a clinical registry (JIPAD) as gold standard.
- Comprehensive assessment with sensitivity/specificity for binary variables and ICCs for continuous variables.
Limitations
- Analysis limited to successfully matched records; case ascertainment not evaluated.
- Retrospective administrative data may suffer from coding variation and unmeasured confounding.
Future Directions: Improve capture of comorbidities and noninvasive respiratory support in DPC; algorithmic phenotyping for organ dysfunction; linkage/merge strategies with JIPAD for hybrid datasets.
BACKGROUND: The Diagnosis Procedure Combination (DPC) database is Japan's most widely used administrative inpatient dataset, supporting epidemiological and health services research. While its validity is established for various diagnoses and procedures, accuracy for intensive care unit (ICU) variables has not been directly evaluated using a clinical registry as the gold standard. METHODS: We conducted a multicenter retrospective validation study using four Japanese ICUs. Patient records from the